About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials | 16,755 Studies Recruiting

Clinical TrialsBreast Cancer

Breast Cancer Clinical Trials

Browse 16,755 clinical trials for breast cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 6241-6260 of 16,755 trials

CompletedThe Potential Cardioprotective Effect of Addition of Atorvastatin in Breast Cancer Patientsthe study aims to evaluate the cardioprotective effect of atorvastatin in breast cancer female patients treated with doxorubicin based chemotherapyNCT07668076·Beheira, Damanhour RecruitingGzmB-PET/CT to Evaluate Neoadjuvant Therapy Efficacy in Breast CancerTo explore the efficacy of 68Ga-GZMB PET/CT in assessing the response to neoadjuvant therapy for breast cancer, and to investigate the optimal SUVmax threshold of 68Ga-GZMB PET/CT…NCT06725940·Shanghai CompletedEffect of Physical Exercise on Tumor Proliferation of Luminal B Breast Cancer PatientsObservational study to evaluate the effect of physical exercise prior to surgery and adjuvant systemic treatment in women with newly diagnosed operable hormone…NCT03860740·Madrid CompletedEfficacy and Safety Study of LEP-ETU to Treat Metastatic Breast CancerLEP-ETU is a novel, proprietary delivery system of paclitaxel developed by NeoPharm, Inc. Paclitaxel (currently marketed as Taxol) is an anti-microtubular network agent and is…NCT01190982·Banjara Hills, Hyderabad and 2 others

Related Searches

breast carcinomatrials

Data from ClinicalTrials.govTerms

RecruitingA Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)The purpose of this study is to understand treatment adherence and patient-reported outcomes of switching to giredestrant due to prior aromatase inhibitor (AI) intolerance.NCT07541079·Fountain Valley, California and 3 others

UnknownSmart Optical and Ultrasound Diagnostic of Breast CancerSOLUS is a trans-disciplinary 48-month project bringing together 9 partners: industries (4), academic and clinical institutions from 5 countries (engineers, physicists and…NCT05916703·Milan

CompletedStudy to Compare the Efficacy and Safety of F-627 and GRAN®A Phase III, Multi-Center, Randomized, Open-Label, Active-Controlled Trial to Compare the Efficacy and Safety of Recombinant Human Granulocyte Colony Stimulating Factor-Fc Fusion…NCT04174599·Shanghai, Shanghai Municipality

CompletedComparison Study of Breast Computed Tomography (CT) With Magnetic Resonance Imaging (MRI)Lay Summary After patients are diagnosed with breast cancer, they undergo breast magnetic resonance (MR) imaging to determine if the cancer is located in more than one place in…NCT00957099·Atlanta, Georgia

CompletedMetronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid TumoursThis is a phase I/II national, multicentre, multiple cohort, prospective open-label, non-randomised and non-comparative study, to evaluate the safety and activity of metronomic…NCT03518606·Angers and 8 others

TerminatedPhase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast CancerThis is a multi-institutional, single arm, open label, Phase Ib/II study of abemaciclib in combination with elacestrant in patients with HR+/Her2- breast cancer metastatic to the…NCT04791384·Aurora, Colorado and 3 others

CompletedA Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast CancerA Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment with Focus on Mechanisms of Resistance to Endocrine Treatment…NCT02958852·Lund

CompletedPresentation of First Time Attenders at Lymphedema ClinicsThe first aim of this research project is to identify what factors motivate patients to seek assessment for early lymphedema and further, to gain insight into the signs and…NCT03687749·Sydney, New South Wales and 1 other

TerminatedPreoperative and Intraoperative Quantification of Axillary Tumoral LoadAt present, patients diagnosed of a breast cancer with infiltration of the axillary lymph-nodes are submitted to axillary lymph-node dissection (ALND).NCT02197949·Barcelona, Barcelona

CompletedDIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast CancerPreclinical studies provide strong support for the concept that fasting evokes resistance to multiple forms of stress.NCT02126449·Leiden, South Holland and 14 others

CompletedFirst-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid TumorsThis is a Phase 1, first-in-human, open-label study designed to evaluate the maximum tolerated dose (MTD), recommended phase 2 dose (RP2D), safety, tolerability, pharmacokinetics…NCT05759949·Orlando, Florida and 6 others

CompletedEvaluating and Comparing Two Surgical Methods for Treatment of Early Stage Breast CancerThe goal of this study is to compare two different types of breast surgery. In the first type, the doctor removes only the tumor.NCT01271738·Atlanta, Georgia

UnknownTw HER2 Positive Breast Cancer Productivity & Utility StudyBreast cancer ranks top 4 Taiwan mortality cause in 2016 and the incidence rate has been increasing.NCT04011085·Taipei

RecruitingPhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)The goal of this research study is to compare a combination of two drugs, capecitabine and elacestrant to capecitabine alone as a treatment for advanced estrogen receptor-positive…NCT07222215·Boston, Massachusetts

UnknownEvaluating and Following Breast Cancer Patients in a Better WayThe current observational study aims at analysing current semiology on breast cancer patients aiming at noting indicators and signs with significant relationship with the disease…NCT03831308

CompletedBRCA1-associated DNA Repair Dysfunction in Patients With Early Triple Negative Breast Cancer Treated With Neoadjuvant Platinum-based ChemotherapyThe purpose of this study is to assess efficacy of platinum-based neoadjuvant chemotherapy in correlation with BRCA1-associated DNA repair dysfunction in patients with early…NCT01672671·Moscow

PreviousPage 313 of 838Next